Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.38 |
| ▸ | PTPRF | P10586 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | STS | P08842 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SCN1A | P35498 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10092015 | 0.86 | CHRNA7 (0.41) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL10092009 | 0.69 | PTPN1 (0.54) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL10092005 | 0.66 | CHRNA7 (0.48) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL10092004 | 0.64 | PTPN1 (0.68) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL10092182 | 0.64 | PTPN1 (0.48) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL1976081 | 0.64 | STS (0.62) | PTPN1PTPN2PTPRFSMN1; SMN2NPC1 | |
| SCHEMBL1899821 | 0.63 | PTPN1 (0.40) | PTPN1PTPN2PTPRFPTPN6PTPN11 | |
| SCHEMBL6399730 | 0.63 | MEN1 (0.56) | SMN1; SMN2STSLMNAMAPTNPSR1 | |
| SCHEMBL110657 | 0.62 | SMN1; SMN2 (0.68) | PTPN1PTPN2PTPRFSMN1; SMN2NPC1 | |
| SCHEMBL14039909 | 0.61 | PTPN1 (0.53) | PTPN1PTPN2PTPRFPTPN6PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| EP-2065890-B1 | Optical recording composition and holographic recording medium | FUJIFILM CORP (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-2065890-A2 | Optical recording composition and holographic recording medium | FUJIFILM Corporation (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CACNA1S, CACNA1E, CRY1 | PTPN1 2628/4885PTPN2 3341/4885PTPRF 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.